🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/06/2009 | 41,63 | 41,75 | 40,98 | 41,46 | -0,11% | 1,84% | 471.000 |
| 09/06/2009 | 41,20 | 41,63 | 41,05 | 41,50 | +0,65% | 1,41% | 345.400 |
| 08/06/2009 | 40,98 | 41,72 | 40,63 | 41,23 | -0,94% | 2,66% | 505.800 |
| 05/06/2009 | 41,57 | 41,82 | 40,71 | 41,62 | +1,01% | 2,67% | 604.000 |
| 04/06/2009 | 41,10 | 41,81 | 40,75 | 41,21 | -0,50% | 2,57% | 691.800 |
| 03/06/2009 | 40,22 | 41,87 | 40,20 | 41,41 | +2,15% | 4,15% | 1.036.400 |
| 02/06/2009 | 39,40 | 41,04 | 39,40 | 40,54 | +1,32% | 4,18% | 944.800 |
| 01/06/2009 | 39,98 | 40,33 | 39,62 | 40,01 | +0,11% | 1,79% | 1.194.000 |
| 29/05/2009 | 39,66 | 40,08 | 39,33 | 39,97 | +0,00% | 1,89% | 1.578.600 |
| 28/05/2009 | 39,11 | 40,35 | 39,09 | 39,97 | +1,99% | 3,23% | 2.245.200 |
| 27/05/2009 | 37,32 | 39,62 | 37,06 | 39,19 | +5,29% | 6,87% | 3.191.000 |
| 26/05/2009 | 36,25 | 37,33 | 36,00 | 37,22 | +11,86% | 3,66% | 5.230.800 |
| 22/05/2009 | 33,31 | 33,69 | 32,68 | 33,27 | +0,27% | 3,03% | 839.600 |
| 21/05/2009 | 32,90 | 33,61 | 32,67 | 33,18 | -0,15% | 2,86% | 852.000 |
| 20/05/2009 | 32,55 | 33,86 | 32,46 | 33,23 | +3,02% | 4,30% | 1.476.400 |
| 19/05/2009 | 32,00 | 32,37 | 31,36 | 32,26 | +0,80% | 3,16% | 1.334.600 |
| 18/05/2009 | 32,18 | 32,41 | 31,42 | 32,00 | +0,63% | 3,06% | 993.600 |
| 15/05/2009 | 31,86 | 32,00 | 31,22 | 31,80 | +0,54% | 2,46% | 1.137.400 |
| 14/05/2009 | 31,97 | 32,02 | 31,48 | 31,63 | +0,13% | 1,69% | 1.051.400 |
| 13/05/2009 | 32,15 | 32,63 | 31,58 | 31,59 | -3,26% | 3,27% | 1.017.200 |
| 12/05/2009 | 32,72 | 32,93 | 32,27 | 32,66 | -0,37% | 2,02% | 574.800 |
| 11/05/2009 | 32,08 | 33,10 | 31,86 | 32,78 | +1,42% | 3,87% | 993.000 |
| 08/05/2009 | 32,25 | 32,56 | 31,98 | 32,32 | +0,23% | 1,80% | 735.200 |
| 07/05/2009 | 32,33 | 32,68 | 31,98 | 32,24 | +0,62% | 2,18% | 690.800 |
| 06/05/2009 | 33,54 | 33,56 | 31,86 | 32,04 | -3,57% | 5,05% | 879.800 |
| 05/05/2009 | 33,54 | 33,74 | 32,36 | 33,23 | -1,03% | 4,13% | 909.600 |
| 04/05/2009 | 33,73 | 33,73 | 32,95 | 33,57 | +2,74% | 2,31% | 1.418.400 |
| 01/05/2009 | 31,36 | 32,97 | 30,27 | 32,68 | +4,04% | 8,59% | 1.824.400 |
| 30/04/2009 | 31,32 | 32,21 | 31,25 | 31,41 | +1,19% | 3,07% | 1.718.200 |
| 29/04/2009 | 29,74 | 31,58 | 29,73 | 31,04 | +6,91% | 6,20% | 2.252.400 |